According to a new report published by Allied Market Research, titled, “Cell Separation Technologies Market by product, technology, application, end user, and: Opportunity Analysis and Industry Forecast, 2020-2027,”
The global cell separation technologies market size was valued at $8,639.20 million in 2019 and is projected to reach $28,766.14 million by 2027, registering a CAGR of 15.4% from 2020 to 2027.
Cell separation technologies are used to separate cells from group of various cells. The separation of cells are based on their physical properties such as shape, size, and protein expression. Cell separation techniques play a vital role in the treatment of chronic diseases, such as AIDS and cancer. In addition, these are widely used in stem cell research and cancer research. In addition, cell separation market is likely to expand in coming years, as cell-based therapies are widely being adopted for treatment of chronic diseases. As a result, mortality rate associated with chronic diseases is also declining.
Researchers around the world are working earnestly to study SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. The emergence of COVID-19 has changed life. This is a fast-moving and deadly pandemic that requires novel, next-generation technology to enable ongoing research and advanced diagnostic testing. Many cell separation technology companies are offering their products to study COVID-19 infection and also helps in vaccine development, which includes Stemcell Technologies Inc., Akadeum Life Sciences, Miltenyi Biotec, Nanocellect Biomedical and others.
Increase in number of patients suffering from chronic disease and technological advancements in cell technologies primarily drive the growth of the cell separation technologies market. Similarly, surge in focus on personalized medicines for early detection of disease, selection of appropriate treatment, and determination of prognosis of the therapy are further expected to boost the market growth. However, ethical issues related to embryonic stem cell separation and high cost of cell based research hinder the market growth. Conversely, high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the cell separation technologies market growth.
By product, the consumables segment holds the largest share in 2019 and is expected to maintain its dominance throughout the forecast period. This is attributed to increase in investments by the major players in the development of technologically advanced consumable products as well as the frequent use of consumables are the major factors which fuels the growth of this segment.
North America accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure for continuous research in stem cell and targeted therapies, as well as rise is medical tourism.
The cell separation technologies market is segmented on the basis of technology, product, application, end user, and region. By product, the market is bifurcated into instruments and consumables. On the basis of technology, the cell separation technologies market is divided into gradient centrifugation, surface markers separation, and filtration based separation. Surface markers separation is further classified into fluorescence activated cell sorting and magnetic cell sorting. On the basis of application, the market is classified into oncology research, neuroscience research, stem cell research, microbiology, immunology research and other application. By end user, the market is segmented into research laboratories & institute, biotechnology & biopharmaceutical companies, and cell banks. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides some of the key players operating in the cell separation technologies market include Alfa Laval Corporate AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Danaher Corporation, Merck KGaA, Miltenyi Biotec Inc., Pluriselect GmbH, Stemcell Technologies Inc., and Thermo Fisher Scientific. The other players (not profiled in the report) in the value chain include Akadeum Life Sciences, Cytiva Lifesciences, Terumo, 10X Genomics, Zeiss, PerkinElmer, Inc., and among others.
Key Findings Of The Study
- By product, the consumable segment occupied around 60% share of the global cell separation technologies market in 2019.
- By technology, the fluorescence activated cell sorting is anticipated to grow with the highest CAGR throughout the forecast period.
- Based on application, the Oncology Research segment hold the largest share in 2019 and is expected to maintain its dominance from 2020-2027.
- End User wise, the biotechnology & biopharmaceutical companies segment generated the highest revenue in 2019, accounting more than three-fourth of the global market in 2019.
- Asia-Pacific cell separation technologies market is anticipated to experience 17.8% CAGR during the forecast period.